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Abstract
Background: Self-administered computer-assisted blood donor screening strategies may elicit
more accurate responses and improve the screening process.
Methods: Randomized crossover trial comparing responses to questions on a computerized hand-
held tool (HealthQuiz, or HQ), to responses on the standard written instrument (Donor Health
Assessment Questionnaire, or DHAQ). Randomly selected donors at 133 blood donation clinics
in the area of Hamilton, Canada participated from 1995 to 1996. Donors were randomized to
complete either the HQ or the DHAQ first, followed by the other instrument. In addition to
responses of 'yes' and 'no' on both questionnaires, the HQ provided a response option of 'not sure'.
The primary outcome was the number of additional donors deferred by the HQ.
Results: A total of 1239 donors participated. Seventy-one potential donors were deferred as a
result of responses to the questionnaires; 56.3% (40/71) were deferred by the DHAQ, and an
additional 43.7% (31/71) were deferred due to risks identified by the HQ but not by the DHAQ.
Fourteen donors self-deferred; 11 indicated on the HQ that they should not donate blood on that
day but did not use the confidential self-exclusion option on the DHAQ, and three used the self-
exclusion option on the DHAQ but did not indicate that they should not donate blood on the HQ.
The HQ identified a blood contact or risk factor for HIV/AIDS or sexually transmitted infection that
was not identified by the DHAQ in 0.1% to 2.7% of donors.
Conclusion: A self-administered computerized questionnaire may increase risk reporting by
blood donors.
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Background
Infections in blood donors can be transmitted to blood
product recipients. Strategies to reduce the risks to blood
product recipients have involved public education pro-
grams, administration of questionnaires pertaining to
HIV risk factors, the use of a confidential self-exclusion
(CSE) option which allows the donor to indicate in a con-
fidential manner that their blood should not be used for
transfusion, and direct questioning about risk behaviours.
These strategies have been found to eliminate some high
risk [1,2] and some infected units [3]. While there have
been notable decreases in HIV-positive donations [4,5],
some donors, who are aware of their high-risk behaviours
continue to donate without self-deferral [3,6–9].
Serologic testing is now performed on all acceptable do-
nors in Canada. In the past, window-period infections
have been a concern, however the use of highly sensitive
nucleic acid amplification technology (NAT) has now re-
duced this risk of a transfusion-transmitted infection due
to a window-period donation to an estimated one per mil-
lion donations or fewer in the U.S.[10,11]. In Canada,
NAT is used for HIV and HCV screening in blood donors
( [www.bloodservices.ca], accessed March 1, 2002).
Despite the small risk of infection from donated blood,
there is strong public pressure to ensure that all measures
to reduce the risk of transfusion-transmitted infection are
used. A potential role for improved risk factor detection
through pre-donation screening would be to reduce the
risks from as yet unknown blood borne diseases if these
diseases were associated with other known risk groups.
Explicit direct questions instead of indirect references to
high-risk behaviours for HIV/AIDS have been shown to
increase self-deferral rates in donors at least two-fold
[12,13]. It has been estimated that the standard donor
health assessment questionnaire may miss as many as
10% of donors who engage in high-risk behaviours [6].
Studies using various computerized questionnaire meth-
ods have found increased reporting of perceived socially
undesirable behaviors compared to face-to-face interviews
in higher risk groups [14–17], however few have assessed
the usefulness or acceptability of computer-assisted
screening in the blood donation screening process
[18,19].
Figure 1
Flow diagram of the randomized cross-over trial.
Donors Approached to participate (n=1363)
Not Randomized (n=100)
- time constraints (n=71)
- previously enrolled (n=18)
- visual/dexterity problems
(n=4)
- left before staff could
approach (n=7)
Randomized (n=1263)
Completed HQ first (n=604) Completed DHAQ first (n=635)
Randomization order not
recorded (n=24)BMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/14
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This randomized crossover trial among blood donors
compared a self-administered computerized question-
naire (HealthQuiz, or HQ) to the existing Donor Health
Assessment Questionnaire (DHAQ) on consistency of re-
sponses. We also assessed the acceptability and ease of ad-
ministration of the HQ in the donors.
Methods
Participant enrolment
The study was conducted at Canadian Red Cross Society
(CRCS) blood donor events held at one of three clinic site
types in the area of Hamilton, Ontario, Canada, from Feb-
ruary 1995 to February 1996 (n = 133 events). Twenty-
four (18.0%) were held at a permanent clinic in Hamil-
ton, 38 (28.6%) at clinics within 30 minutes drive of the
permanent clinic, and 71 (53.4%) at clinics more than 30
minutes away.
At each event, the research staff used a list of random
numbers that had been prepared earlier, to randomly se-
lect prospective donors who had been assigned an intake
number in sequence by the CRCS staff. Potential subjects
were greeted by study staff and invited to participate in
completing the HQ in addition to the DHAQ. Those who
agreed to be involved were randomly assigned to receive
either the HQ followed by the DHAQ or the DHAQ fol-
lowed by the HQ (Figure 1). The last digit of the partici-
pants' intake number was used to determine the order in
which they received the questionnaire; an odd number in-
dicated one order and an even number indicated the other
order.
All participating donors received training on how to use
the  HQ. Donors were directed to one of the privacy
booths for completion of both questionnaires. After fin-
ishing the first data collection method, subjects returned
to the study personnel to receive the other method. Once
both methods were completed, donors received a short
satisfaction questionnaire that addressed issues regarding
the acceptability and comfort level associated with using
the HQ. After returning this questionnaire to study per-
sonnel, donors rejoined the queue to continue being
processed for donation.
Administration of questionnaires
The HQ was presented on a 22.5 by 26.3 cm portable bat-
tery-operated computer that had been designed for ques-
tionnaire administration. The questions were developed
using the standard written DHAQ. The questions ap-
peared one at a time on a white high-contrast screen in
black letters and were answered by the donor using one of
three large buttons: 'yes', 'no', 'not sure'. Donors contin-
ued through the questionnaire by pressing the 'next ques-
tion' button. The responses triggered a path through the
branching questions. Pre-set algorithms created reports
that were printed immediately and stored in a database.
The printed report indicated that the donor should be ac-
cepted, deferred, or that further investigation was required
by the clinic staff. In addition to the risk questions in the
HQ, questions pertaining to the ease of use and readabil-
ity of the HQ were asked.
At the time of the study, the DHAQ was a self-adminis-
tered list of questions with 'yes' and 'no' boxes that are
checked by the donors. Blood donor clinic staff reviewed
the responses and decided if the donor should be accept-
ed, deferred or questioned further. To conform to the usu-
al clinic standards, donor acceptance or deferral was based
on the responses to the DHAQ, reviewed by the clinic
staff. However, if the research staff noted a potential defer-
ral factor identified on the HQ, it was brought to the atten-
tion of the clinic staff. We did not gather specific
information on the reason for deferral when deferral was
based on the standard DHAQ. For the additional donors
deferred because of a response on the HQ that was not
identified on the DHAQ, the relevant items were noted.
Donors were given the opportunity to indicate on the
DHAQ whether their unit should be used for transfusion
by placing one of two stickers on their form; 'use my
blood' or 'don't use my blood'. A question was asked on
the HQ that gave donors an opportunity to indicate that
there was a reason they should not donate blood on that
day.
Donors who were accepted for donation had blood drawn
for serology for HBsAg, HCV, VDRL, HTLV-1 and 2 and
HIV, using commercially available kits according to man-
ufacturers' instructions.
The DHAQ responses were abstracted to a database by
study staff, who were blind to other data, including the or-
der in which the questionnaires had been presented. Eth-
ical approval for the study was obtained from the
McMaster University ethics review board.
Statistical analysis
The primary analysis compared the number of deferrals
using the DHAQ compared to the additional number
identified by responses to the HQ. Second, the responses
to individual questions were compared between the two
questionnaires. Due to evolving policies and procedures
of the Canadian Red Cross Society, the DHAQ, and con-
sequently the automated questionnaire were modified
twice during the study period and sample sizes for various
questions reflect this. McNemar's Chi-square was used to
determine whether there were significant differences be-
tween the two questionnaires. A probability of a type I er-
ror (alpha) of 0.05 (two-tailed) was used to indicate
statistical significance.BMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/14
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Results
Sample description
Of the 1,363 donors approached, 1,263 (92.7%) agreed
to participate. The reasons given by the 100 non-partici-
pants are shown in Figure 1. Of the 1,263 participating
donors, randomization order was not recorded for 24,
leaving 1,239 participants for analyses. There were 604
donors randomized to receive the HQ first and 635 were
randomized to receive the DHAQ first (Figure 1).
Approximately half of the donors were women (634/
1239, 51.2%) and the mean age of the sample was 34.0
(SD = 14.6) years. Eighty-three percent of the sample
(878/1054) reported an annual household income of
over $CA 24,000 ($1 US = 1.5$CA) and 95.4% (1145/
1200) had completed nine or more years of schooling.
English was spoken at home by 94.5% (1145/1211) of
donors. The two randomized groups were similar on these
characteristics (Table 1).
Ninety-six percent (1184/1239) of the donors had donat-
ed at least once and 81.2% (1006/1239) had donated at
least twice.
Donor deferral
Of the 1239 donors, 5.7% (71/1239) were deferred based
on the questionnaires. Items identified by the HQ nearly
doubled the number of donors who were eventually de-
ferred; 3.2% (40/1239) were deferred on the basis to their
answers to the DHAQ reviewed by the clinic staff and an
additional 2.5% (31/1239) were identified by items on
the HQ which were not identified on the DHAQ. An ad-
ditional 2.1% (26/1239) were deferred because of low
haemoglobin, and 0.2% (2/1239) changed their minds at
bedside. There were no positive serologic tests to HBsAg,
HCV, VDRL, HTLV-1 or 2, or HIV. The items on the HQ
which led to the deferral of the additional 31 donors are
shown in Table 2. Eight donors indicated used of medica-
tion, history of jaundice or hepatitis, receiving blood
products, or having had an AIDS test outside blood donor
screening, while the remaining 23 identified other items
relating to their health history.
A total of 14 people used some form of self-exclusion op-
tion. Eleven people indicated that they had reason to
think that they should not donate blood on that day on
the HQ but did not use the CSE option on the DHAQ, and
three donors self-deferred using the CSE option on the
DHAQ but did not indicate that they should not donate
blood on the HQ (p = 0.008). None of the 14 donors who
used these options used it on both questionnaires.
Response discrepancies between the HQ and the DHAQ
The frequency of discrepancies in which a response of 'yes'
on one instrument changed to 'no' on the other, are
Table 1: Demographic characteristics of the 1239 blood donors randomized to the two orders of administration for the computerized 
HealthQuiz (HQ) and the written Donor Health Assessment Questionnaire (DHAQ).
HQ followed by DHAQ (n = 604) n (%) DHAQ followed by HQ (n = 635) n (%)
Female gender 47.7 (288/604) 54.5 (346/635)
Annual household income > $24,000 83.3 (438/526) 83.3 (440/528)
9 or more years of schooling 95.9 (561/585) 95.0 (584/615)
English spoken at home 94.4 (559/592) 94.6 (586/619)
Age (mean years, SD) 33.9, 14.7 34.1, 14.5
Table 2: The questions answered affirmatively to the computer-
izedHealthQuiz that led to further investigation and deferral 
among 31 donors who would have been accepted using only the 
Donor Health Assessment Questionnaire for screening.
Item No. donors
In the last 3 days have you taken any type of medication 
or drugs (pills, needles) except birth control pills or 
vitamins?
3
Taken Accutane in the past 12 months or Proscar, 
Danazol, or methotrexate ever?
1
Surgery in last 12 months 1
Ever had epilepsy, coma, stroke, repeated seizures, 
fainting
2
Ever had heart or blood pressure problems or heart 
surgery
12
Ever had kidney, lung, or blood condition 7
Been pregnant in the last 6 months or breast-fed in the 
last 3 months
1
Ever had yellow jaundice (other than at birth), hepatitis 
or liver disease
2
Received blood plasma, clotting factors or immune 
globulin in past 12 months
1
Had an AIDS test elsewhere (other than for donating 
blood)
1BMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/14
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shown in Table 3. Symptoms of AIDS were reported on
the HQ but not on the DHAQ by 2.7% (34/1239) of do-
nors (p < 0.001) and 2.3% (29/1211) reported on the HQ
but not on the DHAQ that they had had sex with someone
who may have participated in high-risk activities (p <
0.001). The most common major discrepancy for the
blood contact risk questions in which the risk was denied
on the DHAQ but identified on the HQ was for receiving
blood, plasma, clotting factors or immune globulin in the
past 12 months (2.9%, 36/1239, p < 0.001).
Other common major discrepancies, where a risk was re-
ported on the HQ but denied on the DHAQ included a
history of heart or blood pressure problems (17.4%, 216/
1239,) and a history of a kidney, lung or blood condition
(12.0%, 149/1239) (p for both < 0.001).
In almost all cases where the 'not sure' option was chosen
on the HQ, the response of 'no' had been chosen on the
written DHAQ (Table 4). Symptoms of AIDS were denied
on the DHAQ but answered 'not sure' by 2.3% (29/1239).
The largest discrepancy for the blood contact risk ques-
tions occurred for having received blood, plasma, clotting
factors or immune globulin in the last 12 months. This
question was denied on the DHAQ but answered 'not
sure' on the HQ by 4.8% (60/1239). Among the minor
Table 3: Discrepancies on responses (yes to no, or no to yes) between the HealthQuiz (HQ) and the Donor Health Assessment Ques-
tionnaire (DHAQ) among the 1239 study participants.
Questions Risk identified 
on HQ and 
denied on 
DHAQ n (%)
Risk identified 
on DHAQ and 
denied on HQ n 
(%)
p value for 
McNemar's Chi 
square test
Risk for HIV/AIDS or STDs
Since 1977, have you participated in any of the activities that put one at risk for 
AIDS?*
4/1211 (0.3) 0 0.13
Have you even once shared needles or taken street drugs by needle? 1/101 (0.1) 0 1.00
In the last 12 months have you had sex with someone who may have participated 
in high-risk activities (sexual background uncertain)?
29/1211 (2.4) 5/1211 (0.4) 0.001
Have you had an AIDS test elsewhere (other than for donating blood)? 8/1239 (0.6) 13/1239 (1.0) 0.383
Had symptoms of AIDS? † 34/1239 (2.7) 2/1239 (0.2) <0.001
In the last 12 months have you had a tattoo, ear-piercing, acupuncture, electrolysis, 
needle stick injury or graft?
14/1216 (1.2) 8/1216 (0.7) 0.286
Have you ever had yellow jaundice (other than at birth), hepatitis or liver disease? 17/1216 (1.4) 0 <0.001
In the last 12 months to your knowledge have you come in close (intimate) contact 
with someone with yellow jaundice or hepatitis?
1/1239 (0.1) 0 1.00
In the last 12 months have you received blood, plasma, clotting factors or immune 
globulin?
36/1239 (2.9) 1/1239 (0.1) <0.001
Medication Use
In the last 3 days have you taken any type of medication or drugs, except birth 
control pills or vitamins?
68/1239 (5.5) 27/1239 (2.2) <0.001
Have you taken Accutane or Tegison for a skin disorder or growth hormone 
(human pituitary)?
7/1123 (0.6) 0 0.02
In the last month have you taken Accutane for a skin disorder, Proscar or Dana-
zol?
1/94 (1.1) 0 1.00
Illness or exposure
Are you free from cold, flu, infection or active allergy today? 50/1239 (4.0) 3/1239 (0.2) <0.001
Have you had a vaccination in the last 3 months or a rabies shot in the last year? 12/1239 (1.0) 7/1239 (0.6) 0.36
Have you had surgery in the last 6 months? 16/1239 (1.3) 4/1239 (0.3) 0.01
Have you had any of the following?
Epilepsy, coma, stroke, repeated seizures or fainting 21/1239 (1.7) 8/1239 (0.6) 0.02
Heart or blood pressure problems or heart surgery 216/1239 (17.4) 3/1239 (0.2) <0.001
Cancer, diabetes, ulcerative colitis or Crohn's disease 17/1239(1.4) 4/1239 (0.3) 0.007
Kidney, lung or blood condition 149/1239 (12.0) 4/1239 (0.3) <0.001
Have you been pregnant in the last 6 months or breastfed in the last 3 months? 3/1239 (0.2) 1/1239 (0.1) 0.625
In the last 3 years have you lived in or visited an area where malaria is common? 3/1239 (0.2) 1/1239 (0.1) 0.625
* these activities included: if male, having sex with another male, even once; sharing needles or taking street drugs by needle; receiving regular treat-
ment with blood or blood products; being the sexual partner of someone who has taken part in any of the above activities or who has contracted 
AIDS or has tested positive for AIDS † the symptoms of AIDS included: weight loss, night sweats, fever, diarrhea or cough; lumps in the armpits, 
neck or groin, coloured patches on skin or inside mouthBMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/14
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discrepancies, the most common question denied on the
DHAQ but answered 'not sure' on the HQ occurred for the
question regarding taking Accutane or Tegison for a skin
disorder, or taking a growth hormone (10.5%, 118/
1123). The remaining minor discrepancies of this type
were reported in up to 5% of cases (Table 4).
Acceptability of the HQ to donors
The automated HQ was acceptable to a majority of the do-
nors who responded to the questions, such that 82.7%
(1011/1222) reported that it was not difficult to use,
88.4% (1080/1222) did not have trouble reading the
questions, and 86.1% (1053/1222) understood all of the
questions. These responses were not associated with age,
sex, education or previous donor experience (data not
shown).
Discussion
Using the computerized HQ, the number of donors that
were eventually deferred was nearly double the number
that was deferred based on the written DHAQ, and eleven
donors indicated on the computerized HQ that there was
some reason they should not donate blood on that day,
but did not use the CSE option on the DHAQ. Risks relat-
ed to blood-borne infections accounted for a small
number of the items identified by the HQ that were not
identified by the DHAQ, however the detection of even a
small number of such individuals could potentially pre-
Table 4: Discrepancies on responses (yes to not sure, or no to not sure) between the HealthQuiz (HQ the Donor Health Assessment 
Questionnaire (DHAQ) among the 1239 study participants.
Questions "Not sure" of risk on HQ and 
risk denied on DHAQ n (%)
Risk identified on DHAQ and 
"not sure" of risk on HQ n (%)
Risk for HIV/AIDS or STDs
In the last 12 months have you had sex with someone who may 
have participated in high risk activities (sexual background uncer-
tain)?
8/1211 (0.7) 0
Have you had an AIDS test elsewhere (other than for donating 
blood)?
6/1239 (0.5) 2/1239 (0.2)
Had symptoms of AIDS?* 29/1239 (2.3) 0
Blood Contact Risk
Have you ever had yellow jaundice (other than at birth), hepatitis, 
or liver disease?
2/1216 (0.2) 0
In the last 12 months to your knowledge have you come in close 
(intimate) contact with someone with yellow jaundice or hepatitis?
7/1239 (0.6) 0
Medication Use
In the last 3 days have you taken any type of medicine or drugs, 
except birth control pills?
13/1239 (1.0) 9/1239 (0.7)
Have you taken Accutane or Tegison for a skin disorder or growth 
hormone (human pituitary)?
118/1123 (10.5) 0
In the last month have you taken Accutane for a skin disorder, 
Proscar or Danazol?
7/94 (7.4) 0
Illness or Exposure
Are you free from a cold, flu, infection or active allergy today? 1/1239 (0.1) 4/1239 (0.3)
Have you had a vaccination in the last 3 months or a rabies shot in 
the last year?
28/1239 (2.3) 1/1239 (0.1)
Have you had surgery in the last 6 months? 4/1239 (0.3) 3/1239 (0.2)
Have you had any of the following?
Epilepsy, coma, stroke, repeated seizures or fainting 9/1239 (0.7) 1/1239 (0.1)
Heart or blood pressure problems or heart surgery 62/1239 (5.0) 0
Cancer, diabetes, ulcerative colitis or Crohn's disease 14/1239 (1.1) 1/1239 (0.1)
Kidney, lung or blood condition 23/1239 (0.6) 0
Have you been pregnant in the last 6 months or breastfed in the 
last 3 months?
7/1239 (0.6) 1/1239 (0.1)
Have you ever had malaria? 12/1239 (1.0) 0
In the last 3 years have you lived or visited an area where malaria 
is common?
28/1239 (2.3) 1/1239 (0.1)
* the symptoms of AIDS included: weight loss, night sweats, fever, diarrhoea or cough; lumps in the armpits, neck or groin, coloured patches on 
skin or inside mouthBMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/14
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vent a high risk donation. Although there were no serop-
ositive donors in this study, the HQ identified additional
donors who may have been at increased risk of acquiring
a blood borne infection through various risk behaviours.
The identification of high risk donors also has important
implications for avoiding as yet unknown blood-borne
infections.
Our finding, that the computerized HQ identified 2.4% of
donors with risk factors for HIV/AIDS and sexually trans-
mitted infections that were not identified on the written
DHAQ is not unique. In a randomized crossover trial in
the U.S., an additional 4.4% of donors with HIV risks or
AIDS symptoms were identified when using a computer-
based interview which asked about activities that place
them at high risk for HIV, compared to the American Red
Cross standard written questionnaire and interview [20].
Another study in the U.S. suggests that people may be
more likely to respond truthfully about risk behaviours
when questioning is anonymous [21]. In that study, a
questionnaire mailed one to two months following a do-
nation identified a risk factor that should have resulted in
deferral of their donation among 2% of respondents. Of
the respondents who reported risks only on the mailed
survey, 8% of their donations had been rejected for trans-
fusion due to a positive laboratory test.
Previous survey research on sexual behavior, smoking, al-
cohol, and drug use, has found that use of a computer-as-
sisted questionnaire increased reporting of "stigmatized"
behaviors compared to face-to-face interviews [14–
17,22,23]. However, some of these studies [16,17,23]
were limited by the lack of random allocation or rand-
omized cross-over of the participants to the different
screening methods, therefore it cannot be determined
whether the differences in reporting were due to the differ-
ent screening methods rather than differences in partici-
pants characteristics. In addition, all but one [22] of these
studies were conducted in injection drug users at a needle
exchange program, in gay men, and in women attending
a sexually transmitted diseases clinic, therefore the results
may not be generalizable to blood donor populations.
The finding in the present study that the computerized
screening approach was feasible and acceptable to donors
is similar to previous studies [18,19]. Comfort with the
screening process and privacy of responses are important
issues in eliciting accurate and honest responses. In a pre-
vious study, donors with unreported deferrable risk fac-
tors and with reactive infectious disease screening
reported being more likely to disclose personal informa-
tion to a computer [18].
A limitation of the present study and of other literature
comparing two methods of self-reported information
[15–17,22,23], was our inability to conclude that the HQ
identified high-risk donors, in the absence of a gold stand-
ard. Since none of the donors in the present study were re-
active for transmissible infections, we used deferral as a
surrogate marker for high risk donors. Other studies in
North America have also reported low rates of antibodies
in blood donors. The sero-prevalence of HIV was 0.02%
among 123,608 Canadian donors during 1985 [6] and
was 0.03% in the U.S. among blood donors in 1995 [21].
Despite the current low seroprevalence of infections in
blood donors in North America, a recent study has found
that new cases of HIV, HCV, and HBV were as common
among frequent donors as among infrequent donors [24],
suggesting that caution must still be used in blood donor
screening strategies.
Previous research has suggested that the limitations of
screening questionnaires in identifying ineligible donors
may in part be due to the donors' failure to carefully read
the instructions or understand the information [8]. In one
study, some HIV-positive donors failed to exclude their
donated units because of difficulty understanding the
written explanation of the self-exclusion process [25].
While it may be that donors were more willing to disclose
facts that made them ineligible for blood donation on a
computerized questionnaire, other factors could have in-
fluenced the responses. Most of the donors were repeat
donors and were familiar with the written DHAQ ques-
tions and format. Therefore, some donors may not have
read the questions carefully, leading to inaccurate an-
swers. The items for which the largest number of donors
answered negative on the DHAQ but positive on the HQ
were items which had multiple individual questions on
the HQ but were listed in one question on the DHAQ. The
high frequency of reporting on the HQ for items such as
having heart or blood pressure problems or heart surgery
(17.4%), and a kidney, lung or blood condition (12.0%)
is surprising and suggests that some donors may not have
understood or carefully read these questions. Affirmative
answers to these questions on the DHAQ would have led
to further review of the responses with the clinic staff and
would have likely resulted in changes to the responses,
otherwise the deferral rate would have been much higher.
Without further staff investigation, healthy risk-free do-
nors could mistakenly be deferred if questions on a self-
administered questionnaire are not understood. These re-
sults highlight the need for careful evaluation of a compu-
terized screening process to ensure that accurate
information is obtained without burdening clinic staff.
A computerized questionnaire may improve the efficiency
of the donor screening process. The computer was easy to
use and the data that were entered into the computer were
immediately available as a printed report and in electronic
medium for storage. Transcription errors were eliminatedBMC Public Health 2002, 2 http://www.biomedcentral.com/1471-2458/2/14
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and the database was complete for each potential donor.
A limitation of this study was the inability to compare the
efficiency of the deferral process using the HQ to the usual
process using the written instrument, since no informa-
tion regarding staff resources was obtained.
In response to the increasingly complex and time-con-
suming donor screening process, computer-assisted
screening is currently in place in some areas, and the U.S.
Food and Drug Administration (FDA) has recently provid-
ed draft guidelines for the use of self-administered ques-
tionnaires including those that are computer-assisted
[26,27]. The FDA recommends assessment of the effec-
tiveness of self-administered questionnaires in identifying
unsuitable donors. The randomized cross-over trial is a
useful methodology for this type of assessment, both to
identify unclear or problematic questions and to have a
valid comparison of responses to the two methods within
each individual. Studies presenting different testing meth-
ods to different individuals, especially in a non-rand-
omized fashion, cannot provide such comparisons.
While the risk to blood product recipients of contracting
infections from blood products has been dramatically re-
duced with the use of new diagnostic technologies, this
study suggests that it may be possible to further improve
the blood donor screening process. In addition to exclud-
ing high-risk donors, donor health assessment is carried
out to include healthy risk-free donors and to protect in-
dividuals with medical conditions from possible adverse
effects of donating. While we cannot conclude that the in-
creased number of deferrals and risk factors identified in
this study resulted in an improvement in the donor
screening process, a computerized instrument may have
the potential to improve this process if more truthful an-
swers are elicited.
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